Assembly Biosciences (ASMB) Tax Provisions (2016 - 2024)
Assembly Biosciences' (ASMB) quarterly Tax Provisions came in at -$76000.0 in Q4 2024, down 330.3% year-on-year from $33000.0 in Q1 2024, and down 118.72% quarter-over-quarter from $406000.0 in Q2 2024.
Assembly Biosciences (ASMB) Tax Provisions (2016 - 2024) Analysis & Trends
Assembly Biosciences' Tax Provisions history runs 6 years deep, the most recent figure standing at -$76000.0 for Q4 2024.
- On a quarterly basis, Tax Provisions fell 330.3% year-over-year to -$76000.0 in Q4 2024; TTM through Dec 2025 was -$76000.0, a 120.94% decrease from a year earlier, with the FY2024 full-year figure at $330000.0, up 900.0% from the prior year.
- Tax Provisions eased to -$76000.0 in Q4 2024 per ASMB's latest filing, from $406000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $406000.0 in Q2 2024 and bottomed at -$76000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -76,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2019 | -741,000.00 |
| Sep 30, 2019 | -15,000.00 |
| Jun 30, 2019 | -11,000.00 |
| Mar 31, 2019 | -7,000.00 |
| Dec 31, 2018 | 40,000.00 |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2018 | -34,000.00 |
| Dec 31, 2017 | 105,416.00 |
| Sep 30, 2017 | -35,903.00 |
| Jun 30, 2017 | -69,513.00 |
| Dec 31, 2016 | -618,000.00 |